Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $3.92 USD
Change Today -0.09 / -2.24%
Volume 9.4K
As of 2:39 PM 03/30/15 All times are local (Market data is delayed by at least 15 minutes).

skystar bio-pharmaceutical (SKBI) Snapshot

Open
$3.99
Previous Close
$4.01
Day High
$4.03
Day Low
$3.92
52 Week High
07/3/14 - $8.22
52 Week Low
03/16/15 - $3.62
Market Cap
34.1M
Average Volume 10 Days
9.1K
EPS TTM
$1.33
Shares Outstanding
8.7M
EX-Date
--
P/E TM
3.0x
Dividend
--
Dividend Yield
--
Current Stock Chart for SKYSTAR BIO-PHARMACEUTICAL (SKBI)

Related News

No related news articles were found.

skystar bio-pharmaceutical (SKBI) Related Businessweek News

No Related Businessweek News Found

skystar bio-pharmaceutical (SKBI) Details

Skystar Bio-Pharmaceutical Company researches, develops, produces, markets, and sells veterinary healthcare and medical care products in the People’s Republic of China. The company offers micro-organism products, veterinary medicines for poultry and livestock, feed additives, and bio-pharmaceutical veterinary vaccines. It markets its products through distributers and franchise distributors, as well as directly to customers. The company is headquartered in Xi’an, the People’s Republic of China.

skystar bio-pharmaceutical (SKBI) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $121.6K
Chief Financial Officer
Total Annual Compensation: $182.5K
Compensation as of Fiscal Year 2013.

skystar bio-pharmaceutical (SKBI) Key Developments

Skystar Bio Pharmaceutical Company Announces Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2014; Reiterates Earnings Guidance for the Fiscal 2014

Skystar Bio Pharmaceutical Company announced unaudited consolidated earnings results for the third quarter and nine months ended September 30, 2014. For the quarter, the company reported revenue of $18,352,693 against $15,992,408 a year ago. Income from operations was $5,399,574 against $4,737,701 a year ago. Net income was $4,909,453 against $3,734,197 a year ago. Income before provision for income taxes was $5,622,387 against $4,516,174 a year ago. Diluted earnings per share were $0.57 against basic and diluted earnings per share of $0.49 a year ago. For the nine months, the company reported revenue of $39,424,886 against $32,858,294 a year ago. Income from operations was $9,939,652 against $10,354,234 a year ago. Net income was $8,695,663 against $8,197,811 a year ago. Income before provision for income taxes was $10,521,013 against $9,997,829 a year ago. Diluted earnings per share were $1.08 against basic and diluted earnings per share of $1.08 a year ago. Net cash provided operating activities was $15,244,465 against net cash used in operating activities of $9,092,042 a year ago. Purchases of property, plant and equipment were $8,645 against $9,290 a year ago. The company reiterated its fiscal 2014 guidance to be in the range of $46 million to $50 million for the full year.

Skystar Bio Pharmaceutical Company to Report Q3, 2014 Results on Nov 14, 2014

Skystar Bio Pharmaceutical Company announced that they will report Q3, 2014 results at 5:00 PM, China Standard Time on Nov 14, 2014

Skystar Bio Pharmaceutical Company, Q3 2014 Earnings Call, Nov 14, 2014

Skystar Bio Pharmaceutical Company, Q3 2014 Earnings Call, Nov 14, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SKBI:US $3.92 USD -0.09

SKBI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Animal Husbandry Industry Co Ltd CNY21.10 CNY -0.16
Guangdong VTR Bio-Tech Co Ltd CNY36.06 CNY -0.09
Inner Mongolia Jinyu Group Ltd CNY55.48 CNY -0.82
Xinjiang Tecon Animal Husbandry Bio-Technology Co Ltd CNY17.32 CNY +0.74
View Industry Companies
 

Industry Analysis

SKBI

Industry Average

Valuation SKBI Industry Range
Price/Earnings 2.9x
Price/Sales 0.7x
Price/Book 0.3x
Price/Cash Flow 3.2x
TEV/Sales 0.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SKYSTAR BIO-PHARMACEUTICAL, please visit www.skystarbio-pharmaceutical.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.